Fertility
As a leader in fertility treatments, we are dedicated to providing our patients with innovative products and continuous support
for the treatment of infertility, a common condition that affects approximately 7.3 million people in the US. (1)
We are the only company to offer recombinant versions of three hormones used in the treatment of infertility. These include
Gonalf® (follitropin alfa for injection), Ovidrel® Prefilled Syringe (choriogonadotropin alfa injection), and Luveris® (lutropin alfa for injection). Rounding out EMD Serono’s portfolio of fertility treatments is Cetrotide® (cetrorelix acetate for injection) indicated for the inhibition of premature LH surges in women undergoing controlled ovarian
stimulation.
"Becoming a mother was one of the biggest dreams I had growing up."
Lindsay, EMD Serono, Inc. Fertility Patient
Lindsay, EMD Serono, Inc. Fertility Patient
(1) Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women:
Data from the 2002 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat. 2005;23(25).
Important Safety Information
As with all prescription medications, side effects may occasionally occur with use of fertility drugs. Doctors specializing
in fertility or reproductive health should only prescribe these products. Patients prescribed gonadotropins and GnRH analogs
should be monitored carefully by a trained fertility specialist. Risks include the following events which can be serious:
hypersensitivity reactions; ovarian hyperstimulation syndrome (OHSS); pulmonary and vascular complications, and multiple births.
For complete product details about a specific fertility drug, please refer to the Full Prescribing Information.
